Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07278323 · ClinicalTrials.gov registry record · Phase 4
Frozen Shoulder and Hormone Replacement Therapy
A Phase 4 study, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT07278323 is a Phase 4 study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 60 participants.
The verdict
NCT07278323, a Phase 4 study, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of hormone replacement therapy (HRT) in addition to standard treatment on frozen shoulder symptoms in women with age-related changes to their menstrual cycle. Frozen shoulder refers to the condition a doctor diagnosed the participant with regarding shoulder pain, stiffness, and progressive loss of range of motion. Age-related menstrual cycle changes, known as perimenopause and/or menopause, refers to a change or stoppage of monthly menstrual cycles. Other symptoms participants may be experiencing include vaginal dryness, hot flashes, or night sweats. Hormone replacement therapy (HRT) refers to medicine with female hormones in it. For this study, HRT will be in the form of a patch that goes on the skin and a daily oral pill. Participants will be randomly assigned to receive either HRT plus standard care, or only standard care. Follow-up tests will be completed at 6 months of treatment to assess participant progress.
Interventions
- DRUG Hormone Replacement Therapy (HRT)
- DRUG Corticosteroid and 1%lidocain
- BEHAVIORAL physical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2026-01-15 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07278323
The ClinicalTrials.gov registry entry for NCT07278323 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Hormone Replacement Therapy (HRT) is the first listed.
NCT07278323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07278323 about?
NCT07278323 is a clinical study titled "Frozen Shoulder and Hormone Replacement Therapy". The purpose of this study is to determine the effects of hormone replacement therapy (HRT) in addition to standard treatment on frozen shoulder symptoms in women with age-related changes to their menstrual cycle. Frozen shoulder refers to the condition a doctor diagnosed the participant with regardi...
What is the current status of trial NCT07278323?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2026-01-15. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07278323?
The interventions under investigation include: Hormone Replacement Therapy (HRT) (DRUG), Corticosteroid and 1%lidocain (DRUG), physical therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT07278323?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.